Astrana Health, Inc. (ASTH) vs LeMaitre Vascular, Inc. (LMAT)
A side-by-side comparison of Astrana Health, Inc. and LeMaitre Vascular, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASTH
Astrana Health, Inc.
$37.29HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
LMAT
LeMaitre Vascular, Inc.
$80.23HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — ASTH vs LMAT
growth of $100 · dividends reinvested · last 10yASTH +824.9% (+24.9%/yr)LMAT +349.0% (+16.2%/yr)ASTH compounded faster over this window
ASTH LMAT
ASTH vs LMAT: by the numbers
- •ASTH is the larger company ($1.85B vs $1.83B market cap).
- •LMAT trades at the lower trailing earnings multiple (28.15 vs 45.61 P/E), one valuation lens rather than an overall verdict.
- •LMAT converts more revenue to profit (25.02% vs 1.05% net margin).
- •ASTH grew revenue faster over the past five years (53.77% vs 11.76% CAGR).
- •LMAT pays a dividend (1.17% yield), while ASTH has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ASTH | LMAT |
|---|---|---|
| P/E ratio | 45.61 | 28.15 |
| Forward P/E | 26.68 | 27.93 |
| PEG ratio | N/A | 1.45 |
| P/S ratio | 0.48 | 6.99 |
| P/B ratio | 2.23 | 4.36 |
| EV / EBITDA | 13.57 | 21.97 |
| FCF yield | 8.57% | 4.03% |
Profitability
| Metric | ASTH | LMAT |
|---|---|---|
| Gross margin | 9.22% | 72.90% |
| Operating margin | 2.61% | 29.46% |
| Net margin | 1.05% | 25.02% |
| ROE | 4.88% | 15.62% |
| ROIC | 4.13% | 9.81% |
Dividends
| Metric | ASTH | LMAT |
|---|---|---|
| Dividend yield | N/A | 1.17% |
| Payout ratio | N/A | 33.33% |
Growth (annualized)
| Metric | ASTH | LMAT |
|---|---|---|
| Revenue CAGR (5Y) | 53.77% | 11.76% |
| EPS CAGR (5Y) | -15.06% | 19.42% |
| FCF CAGR (5Y) | 18.35% | 13.06% |
| Total return CAGR (5Y) | -16.52% | 9.79% |
Frequently asked
- Which has the lower trailing P/E, ASTH or LMAT?
- LMAT has the lower trailing P/E: ASTH trades at 45.61 and LMAT at 28.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ASTH or LMAT?
- Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus LMAT at 11.76%.
- Does ASTH or LMAT pay a bigger dividend?
- LMAT pays a dividend (1.17% yield), while ASTH has no payments in the available dividend history.
- Is ASTH or LMAT more profitable?
- LMAT runs the higher net margin — ASTH at 1.05% versus LMAT at 25.02%.
- How have ASTH and LMAT total returns compared?
- Over the past 10 years, ASTH delivered 25.17% and LMAT delivered 16.21% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Astrana Health P/E ratioLeMaitre Vascular P/E ratioLeMaitre Vascular dividend yieldAstrana Health ROELeMaitre Vascular ROEAstrana Health operating marginLeMaitre Vascular operating marginAstrana Health revenue growthLeMaitre Vascular revenue growthAstrana Health free cash flowLeMaitre Vascular free cash flow
Astrana Health & LeMaitre Vascular appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.